Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
暂无分享,去创建一个
L. Young | D. Jones | M. Rowe | G. Niedobitek | D. Wright | D. Wright | A. Agathanggelou | J. Oryema | Db Jones | E. Jones | P. Turyaguma | J. Oryema
[1] E. Kieff. Epstein-Barr virus and its replication , 1996 .
[2] G. Niedobitek. Patterns of Epstein-Barr virus infection in non-Hodgkin's lymphomas. , 1995, The Journal of pathology.
[3] L. Young,et al. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. , 1994, The American journal of pathology.
[4] M. Diomande,et al. HIV‐associated lymphoma in Africa: An autopsy study in Ĉote D'ivoire , 1994, International journal of cancer.
[5] Martine,et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. , 1993, The American journal of pathology.
[6] S. Burrows,et al. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. , 1993, Journal of Immunology.
[7] K. Bhatia,et al. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. , 1993, Leukemia research.
[8] M. Gulley,et al. Posttransplantation lymphoproliferative disorders. , 1993, American journal of clinical pathology.
[9] L. Young,et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.
[10] H. Stein,et al. Epstein-Barr virus and CD30+ malignant lymphomas. , 1993, Critical reviews in oncogenesis.
[11] F. Grässer,et al. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein. , 1992, Virology.
[12] M. Rowe,et al. Restoration of the LFA‐3 adhesion pathway in Burkitt's lymphoma cells using an LFA‐3 recombinant vaccinia virus: consequences for T cell recognition , 1992, European journal of immunology.
[13] E. Kieff,et al. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[14] E. Kieff,et al. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies , 1992, The Journal of experimental medicine.
[15] E. Kieff,et al. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.
[16] S. Swerdlow,et al. Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease , 1992, Histopathology.
[17] A. Rickinson,et al. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes , 1992, Journal of virology.
[18] H. Stein,et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. , 1992, Blood.
[19] L. Young,et al. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. , 1991, The Journal of general virology.
[20] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[21] G. Packham,et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia , 1991, Journal of virology.
[22] S. Pileri,et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Fåhraeus,et al. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Rowe,et al. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.
[25] M. Yacoub,et al. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. , 1990, Transplantation.
[26] E. Kieff,et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.
[27] Pierre Busson,et al. Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma , 1988, International journal of cancer.
[28] A. Rickinson,et al. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance , 1988, The Journal of experimental medicine.
[29] T. Tursz,et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. , 1988, The Journal of general virology.
[30] L. Young,et al. Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.
[31] E. Kieff,et al. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. , 1987, The Journal of general virology.
[32] N. Raab-Traub,et al. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.
[33] J. Steitz,et al. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Evan,et al. Restricted expression of EBV latent genes and T‐lymphocyte‐detected membrane antigen in Burkitt's lymphoma cells. , 1986, The EMBO journal.
[35] H. Hausen,et al. EB viral genomes in epithelial nasopharyngeal carcinoma cells. , 1973, Nature: New biology.
[36] G. Klein,et al. Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.